Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Cientifica: How Nanotechnology is Revolutionizing Drug Delivery

Abstract:
Nanotechnology-enabled drug delivery systems (DDS) are dramatically reshaping the way existing drugs are delivered, establishing new opportunities for drug formulation and creating a host of new DDS companies resulting in the opening of a whole new era in the treatment of diseases.

Cientifica: How Nanotechnology is Revolutionizing Drug Delivery

London, UK | Posted on October 18th, 2007

Cientifica, the world's leading independent supplier of nanotechnology research and technology information, in its recently released free White Paper "The Nanotech Revolution in Drug Delivery" reveals that a new value paradigm has taken place in the drug delivery market in which pharma companies' existing compounds have new value.

"At present, several hundred billion dollars worth of existing compounds which cannot be delivered properly are sitting in IP vaults unused," explains Hailing Yu, Research Director for Cientifica and principal author of the report. "The industry is keen to unlock and exploit this valuable intellectual property, and using nanotechnology to create New Chemical Entities (NCEs) via reformulation gives them the key."

The impact on the DDS market is already significant, with Cientifica estimating that nano-enabled DDS already represents a $3.39 billion market and prompting a scramble by both large pharmaceutical companies and drug delivery start ups to grab a piece of a market predicted to grow to $26 billion by 2012, representing a compound annual growth rate of 37% over the next five years.

"After that, the market is poised to explode," explains Cientifica CEO Tim Harper, "with the fruits of today's research and development in both drug delivery systems and nanomaterials feeding through to create a market worth $220 billion by 2015."

The revolutionary impact of nano-enabled also promises to transform the clinical treatment of patients with a range of diseases from cancer to dermatitis, and offers a range of delivery options for compounds that are either poorly soluble or those that may also harm healthy tissue.

The White Paper is a companion to Cientifica's recently released report "The Nanoparticle Drug Delivery Market", which identifies and analyses the companies and players that are likely to benefit as nanotechnology reshapes the drug delivery market.

####

About Cientifica
Cientifica is the world's leading independent supplier of nanotechnology research and technology information, with activities spanning from basic research to consultancy, business intelligence and investments.

For more information, please click here

Contacts:
Cientifica
Tim Harper
+44 7894 70 89 89

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Bruker Awarded Fourth PeakForce Tapping Patent: AFM Mode Uniquely Combines Highest Resolution Imaging and Material Property Mapping July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE